Luca Durelli

Medicine · Health Sciences

41h-index6.7kcitations258works1.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(103), Peripheral Neuropathies and Disorders(41), Systemic Lupus Erythematosus Research(29), Polyomavirus and related diseases(27), Cytokine Signaling Pathways and Interactions(23)

Publications251 total

Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS study
Multiple Sclerosis Journal·2020· 16 cited
Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis
Frontiers in Immunology·2019· 36 citedOpen Access
Six year prospective immunological study of Alemtuzumab treated patients: focus on CD4+ T cell subsets (P5.360)
Neurology·2018· 2 cited
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS
Multiple Sclerosis Journal·2018· 23 citedOpen Access
Lack of CD4 + T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses
Journal of Neuroimmunology·2017· 8 citedOpen Access
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis
Expert Opinion on Drug Safety·2017· 32 citedOpen Access
Natalizumab in Multiple Sclerosis: Long-Term Management
International Journal of Molecular Sciences·2017· 80 citedOpen Access
A four year immunological study of responsive and non responsive MS patients after alemtuzumab to search for indications of retreatment (P5.398)
Neurology·2017· 1 cited
Possible cerebral toxoplasmosis in a fingolimod-treated MS patient (P5.389)
Neurology·2017
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML
Neurology·2017· 74 citedOpen Access
Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab
Multiple Sclerosis Journal·2017· 50 cited
Chromatin remodeling in Th17 and Treg plasticity induced by E2 immunomodulation
2017
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Journal of Visualized Experiments·2016· 7 cited
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Journal of Visualized Experiments·2016· 21 citedOpen Access
Alemtuzumab Long Term Immunological Study: The Immunosuppressive Effect Does Not Last More Than 48 Months (S2.008)
Neurology·2016· 6 cited
Cytomegalovirus Reactivation During Alemtuzumab Treatment for Multiple Sclerosis: A Case Report (P2.091)
Neurology·2016· 2 cited
Estrogen Receptor Alpha Regulates Key Genomic Regions of Thelper 17 and T Regulatory Cells in Multiple Sclerosis: A New Potential Biomarker of Disease Activity (P5.348)
Neurology·2016
Alemtuzumab long-term immunologic effect
Neurology Neuroimmunology & Neuroinflammation·2016· 73 citedOpen Access
Cytomegalovirus reactivation during alemtuzumab treatment in a patient with multiple sclerosis
Institutional Research Information System University of Turin (University of Turin)·2016Open Access
Alemtuzumab Long Term Immunological Study: The Immunosuppressive Effect Does Not Last More Than 48 Months
2016· 7 cited
page 1 of 13Next →

Frequent Co-authors

Marinella Clerico(16), Pierangelo Barbero(11), Bruno Ferrero(9), Roberto Mutani(9), E. Verdun(8), B. Bergamasco(8), Mauro Bergui(7), L Bergamini(6), Angelo Ghezzi(5), Dario Cocito(5), M Delsedime(5), Stefania De Mercanti(5), Alessandra Oggero(5), G. Isoardo(5), Francesco Monaco(5), Francesco Novelli(4), Adriano Chiò(4), Maria Roberta Bongioanni(4), Simona Rolla(4), Valentina Bardina(4)